| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ceramides | 227 | 2022 | 578 | 22.020 |
Why?
|
| Sphingolipids | 138 | 2023 | 337 | 20.350 |
Why?
|
| Sphingomyelin Phosphodiesterase | 104 | 2021 | 183 | 18.240 |
Why?
|
| Sphingosine | 113 | 2023 | 315 | 9.630 |
Why?
|
| Saccharomyces cerevisiae | 52 | 2020 | 173 | 8.990 |
Why?
|
| Protein Kinase C | 85 | 2021 | 270 | 8.820 |
Why?
|
| Signal Transduction | 119 | 2021 | 2689 | 6.150 |
Why?
|
| Lysophospholipids | 54 | 2023 | 209 | 5.560 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 43 | 2023 | 201 | 4.990 |
Why?
|
| Neutral Ceramidase | 18 | 2022 | 27 | 4.950 |
Why?
|
| Apoptosis | 88 | 2022 | 1641 | 4.680 |
Why?
|
| Saccharomyces cerevisiae Proteins | 32 | 2020 | 123 | 4.620 |
Why?
|
| Sphingomyelins | 49 | 2015 | 106 | 3.970 |
Why?
|
| Tumor Necrosis Factor-alpha | 45 | 2021 | 626 | 3.910 |
Why?
|
| Cell Membrane | 48 | 2022 | 525 | 3.790 |
Why?
|
| Type C Phospholipases | 22 | 2020 | 67 | 3.530 |
Why?
|
| Acid Ceramidase | 15 | 2020 | 85 | 3.370 |
Why?
|
| Phosphoprotein Phosphatases | 22 | 2012 | 67 | 3.250 |
Why?
|
| Animals | 251 | 2022 | 20881 | 3.210 |
Why?
|
| Enzyme Inhibitors | 39 | 2021 | 659 | 3.210 |
Why?
|
| Mitochondria | 34 | 2021 | 643 | 3.100 |
Why?
|
| Neoplasms | 23 | 2023 | 1667 | 2.990 |
Why?
|
| Isoenzymes | 35 | 2011 | 308 | 2.960 |
Why?
|
| Doxorubicin | 13 | 2023 | 231 | 2.940 |
Why?
|
| Lipid Metabolism | 23 | 2018 | 186 | 2.900 |
Why?
|
| Humans | 372 | 2023 | 68618 | 2.860 |
Why?
|
| Antineoplastic Agents | 24 | 2021 | 1070 | 2.580 |
Why?
|
| Cell Line, Tumor | 74 | 2021 | 1851 | 2.490 |
Why?
|
| Colonic Neoplasms | 13 | 2021 | 299 | 2.480 |
Why?
|
| Enzyme Activation | 75 | 2020 | 791 | 2.410 |
Why?
|
| Tumor Suppressor Protein p53 | 13 | 2023 | 231 | 2.350 |
Why?
|
| Propanolamines | 9 | 2021 | 70 | 2.310 |
Why?
|
| Tumor Cells, Cultured | 72 | 2021 | 852 | 2.190 |
Why?
|
| Cell Movement | 17 | 2021 | 630 | 2.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 22 | 2020 | 282 | 2.120 |
Why?
|
| Up-Regulation | 28 | 2023 | 682 | 2.110 |
Why?
|
| Membrane Proteins | 28 | 2021 | 617 | 2.110 |
Why?
|
| Alkaline Ceramidase | 13 | 2022 | 35 | 2.100 |
Why?
|
| Amidohydrolases | 16 | 2022 | 60 | 2.050 |
Why?
|
| Mutation | 27 | 2019 | 1213 | 2.050 |
Why?
|
| Cell Line | 64 | 2021 | 1752 | 2.040 |
Why?
|
| Models, Biological | 42 | 2018 | 981 | 2.020 |
Why?
|
| Phospholipase D | 8 | 2017 | 13 | 1.970 |
Why?
|
| Ceramidases | 20 | 2022 | 47 | 1.930 |
Why?
|
| Tetradecanoylphorbol Acetate | 27 | 2017 | 138 | 1.890 |
Why?
|
| Protein Phosphatase 1 | 10 | 2021 | 36 | 1.850 |
Why?
|
| Phosphorylation | 50 | 2021 | 1200 | 1.830 |
Why?
|
| Diglycerides | 31 | 2005 | 49 | 1.770 |
Why?
|
| Cell Adhesion | 10 | 2021 | 324 | 1.760 |
Why?
|
| Golgi Apparatus | 10 | 2021 | 75 | 1.740 |
Why?
|
| Oxidoreductases | 23 | 2018 | 117 | 1.730 |
Why?
|
| Cell Proliferation | 21 | 2021 | 1174 | 1.730 |
Why?
|
| Serine C-Palmitoyltransferase | 12 | 2018 | 17 | 1.700 |
Why?
|
| Mice | 109 | 2022 | 8474 | 1.700 |
Why?
|
| MCF-7 Cells | 14 | 2021 | 80 | 1.690 |
Why?
|
| Cell Cycle | 17 | 2020 | 312 | 1.640 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 7 | 2015 | 134 | 1.630 |
Why?
|
| Kinetics | 56 | 2016 | 1047 | 1.600 |
Why?
|
| Gene Expression Regulation, Fungal | 10 | 2020 | 32 | 1.520 |
Why?
|
| Amides | 8 | 2021 | 86 | 1.510 |
Why?
|
| Gene Expression Regulation, Neoplastic | 15 | 2021 | 756 | 1.490 |
Why?
|
| Breast Neoplasms | 13 | 2021 | 1536 | 1.460 |
Why?
|
| Substrate Specificity | 29 | 2018 | 234 | 1.450 |
Why?
|
| Second Messenger Systems | 22 | 2008 | 53 | 1.440 |
Why?
|
| Protein Phosphatase 2 | 11 | 2020 | 67 | 1.410 |
Why?
|
| Stress, Physiological | 13 | 2016 | 215 | 1.400 |
Why?
|
| Protein Kinase C-alpha | 10 | 2019 | 24 | 1.390 |
Why?
|
| Blood Platelets | 19 | 2006 | 284 | 1.380 |
Why?
|
| Lung Neoplasms | 12 | 2021 | 1173 | 1.370 |
Why?
|
| Research Personnel | 3 | 2021 | 83 | 1.370 |
Why?
|
| Cytoskeletal Proteins | 9 | 2021 | 108 | 1.370 |
Why?
|
| HeLa Cells | 22 | 2021 | 237 | 1.350 |
Why?
|
| Endocytosis | 7 | 2019 | 113 | 1.330 |
Why?
|
| Cell Division | 28 | 2009 | 541 | 1.310 |
Why?
|
| Neoplasm Proteins | 7 | 2020 | 307 | 1.290 |
Why?
|
| Inflammation | 20 | 2021 | 1030 | 1.280 |
Why?
|
| Mass Spectrometry | 18 | 2018 | 284 | 1.230 |
Why?
|
| Serine | 6 | 2021 | 99 | 1.190 |
Why?
|
| Lysosomes | 12 | 2021 | 136 | 1.180 |
Why?
|
| Proto-Oncogene Proteins c-akt | 5 | 2019 | 331 | 1.180 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2021 | 300 | 1.180 |
Why?
|
| Phospholipids | 13 | 2011 | 108 | 1.170 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2019 | 118 | 1.170 |
Why?
|
| Glycosphingolipids | 6 | 2021 | 51 | 1.170 |
Why?
|
| Chemokine CCL5 | 4 | 2018 | 23 | 1.140 |
Why?
|
| Endosomes | 7 | 2017 | 45 | 1.130 |
Why?
|
| Phospholipases | 7 | 2008 | 12 | 1.120 |
Why?
|
| RNA, Small Interfering | 30 | 2016 | 434 | 1.120 |
Why?
|
| Dose-Response Relationship, Drug | 29 | 2021 | 1745 | 1.100 |
Why?
|
| Metabolic Networks and Pathways | 8 | 2018 | 65 | 1.100 |
Why?
|
| Hydroxyurea | 6 | 2019 | 57 | 1.060 |
Why?
|
| Transfection | 34 | 2021 | 782 | 1.060 |
Why?
|
| Multiprotein Complexes | 3 | 2017 | 56 | 1.050 |
Why?
|
| Mitogen-Activated Protein Kinase 13 | 3 | 2017 | 8 | 1.040 |
Why?
|
| Lipids | 8 | 2018 | 298 | 1.030 |
Why?
|
| Blotting, Western | 31 | 2020 | 954 | 1.020 |
Why?
|
| Galactosylgalactosylglucosylceramidase | 10 | 2008 | 39 | 1.000 |
Why?
|
| Head and Neck Neoplasms | 12 | 2019 | 561 | 0.980 |
Why?
|
| Oleic Acids | 6 | 2013 | 40 | 0.980 |
Why?
|
| Molecular Sequence Data | 29 | 2015 | 1447 | 0.980 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 4 | 2019 | 32 | 0.970 |
Why?
|
| src-Family Kinases | 4 | 2021 | 91 | 0.970 |
Why?
|
| Amino Acid Sequence | 26 | 2015 | 1083 | 0.970 |
Why?
|
| Molecular Structure | 15 | 2021 | 397 | 0.960 |
Why?
|
| Brain | 29 | 2015 | 2176 | 0.960 |
Why?
|
| Colitis | 6 | 2017 | 156 | 0.940 |
Why?
|
| Interleukin-6 | 7 | 2015 | 330 | 0.940 |
Why?
|
| RNA, Messenger | 25 | 2015 | 1664 | 0.930 |
Why?
|
| Glucosylceramidase | 5 | 2015 | 50 | 0.930 |
Why?
|
| Fumonisins | 9 | 2015 | 14 | 0.920 |
Why?
|
| Cell Cycle Proteins | 5 | 2020 | 230 | 0.920 |
Why?
|
| Protein Kinase C-delta | 4 | 2008 | 12 | 0.920 |
Why?
|
| Tretinoin | 3 | 2016 | 92 | 0.910 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 13 | 2008 | 174 | 0.910 |
Why?
|
| ErbB Receptors | 9 | 2021 | 239 | 0.910 |
Why?
|
| DNA Damage | 9 | 2017 | 190 | 0.890 |
Why?
|
| Aging | 10 | 2020 | 911 | 0.880 |
Why?
|
| Phosphatidic Acids | 5 | 2005 | 12 | 0.870 |
Why?
|
| NF-kappa B | 16 | 2018 | 432 | 0.870 |
Why?
|
| Down-Regulation | 15 | 2021 | 447 | 0.850 |
Why?
|
| Myristates | 5 | 2008 | 21 | 0.850 |
Why?
|
| Dextran Sulfate | 7 | 2017 | 88 | 0.850 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2021 | 332 | 0.850 |
Why?
|
| Hydrolysis | 22 | 2022 | 144 | 0.830 |
Why?
|
| Protein Kinase C beta | 9 | 2013 | 19 | 0.830 |
Why?
|
| Chromatography, High Pressure Liquid | 15 | 2019 | 381 | 0.820 |
Why?
|
| Protein Transport | 18 | 2018 | 280 | 0.820 |
Why?
|
| Carcinoma, Squamous Cell | 9 | 2019 | 629 | 0.820 |
Why?
|
| Mice, Knockout | 28 | 2021 | 1692 | 0.810 |
Why?
|
| Hot Temperature | 8 | 2013 | 152 | 0.810 |
Why?
|
| Authorship | 1 | 2021 | 18 | 0.800 |
Why?
|
| Structure-Activity Relationship | 18 | 2021 | 420 | 0.790 |
Why?
|
| Goals | 1 | 2021 | 65 | 0.770 |
Why?
|
| Dinoprostone | 6 | 2012 | 110 | 0.760 |
Why?
|
| Models, Molecular | 10 | 2008 | 546 | 0.760 |
Why?
|
| Cell Physiological Phenomena | 5 | 2013 | 19 | 0.760 |
Why?
|
| Fibroblasts | 16 | 2022 | 902 | 0.750 |
Why?
|
| Indoles | 2 | 2021 | 146 | 0.750 |
Why?
|
| Catalytic Domain | 8 | 2019 | 99 | 0.750 |
Why?
|
| Rats | 45 | 2017 | 5300 | 0.750 |
Why?
|
| Prodrugs | 3 | 2017 | 54 | 0.750 |
Why?
|
| Gaucher Disease | 4 | 2015 | 60 | 0.740 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2021 | 114 | 0.740 |
Why?
|
| Retinoblastoma Protein | 8 | 2009 | 75 | 0.740 |
Why?
|
| Protein Structure, Tertiary | 11 | 2015 | 322 | 0.730 |
Why?
|
| Glucosylceramides | 6 | 2015 | 32 | 0.730 |
Why?
|
| Growth Inhibitors | 6 | 2010 | 33 | 0.730 |
Why?
|
| Research | 1 | 2021 | 214 | 0.720 |
Why?
|
| Microfilament Proteins | 4 | 2017 | 102 | 0.720 |
Why?
|
| Palmitic Acid | 8 | 2015 | 51 | 0.720 |
Why?
|
| Stereoisomerism | 17 | 2021 | 169 | 0.710 |
Why?
|
| Nitrobenzenes | 2 | 2017 | 13 | 0.710 |
Why?
|
| Hydrogen-Ion Concentration | 16 | 2016 | 618 | 0.710 |
Why?
|
| Time Factors | 31 | 2018 | 4655 | 0.700 |
Why?
|
| Microscopy, Confocal | 11 | 2018 | 337 | 0.690 |
Why?
|
| Caspases | 17 | 2015 | 194 | 0.690 |
Why?
|
| Homeostasis | 7 | 2019 | 291 | 0.690 |
Why?
|
| Neurodegenerative Diseases | 4 | 2016 | 102 | 0.680 |
Why?
|
| Cell Death | 12 | 2016 | 329 | 0.680 |
Why?
|
| Amines | 4 | 2018 | 98 | 0.680 |
Why?
|
| Cell Survival | 16 | 2021 | 901 | 0.660 |
Why?
|
| Antibiotics, Antineoplastic | 3 | 2018 | 82 | 0.650 |
Why?
|
| Acetates | 2 | 2018 | 74 | 0.650 |
Why?
|
| Adenosine Triphosphate | 11 | 2014 | 314 | 0.640 |
Why?
|
| Protein Isoforms | 7 | 2021 | 246 | 0.640 |
Why?
|
| Sphingosine N-Acyltransferase | 10 | 2021 | 62 | 0.640 |
Why?
|
| Alanine | 1 | 2018 | 38 | 0.630 |
Why?
|
| Arachidonic Acid | 10 | 2003 | 86 | 0.630 |
Why?
|
| Cell Nucleus | 9 | 2009 | 305 | 0.630 |
Why?
|
| Protein Processing, Post-Translational | 5 | 2016 | 284 | 0.630 |
Why?
|
| Calcium | 16 | 2009 | 929 | 0.630 |
Why?
|
| Registries | 1 | 2021 | 733 | 0.620 |
Why?
|
| Neoplasm Metastasis | 3 | 2021 | 306 | 0.620 |
Why?
|
| beta Catenin | 5 | 2018 | 73 | 0.610 |
Why?
|
| Diacylglycerol Kinase | 5 | 2003 | 8 | 0.610 |
Why?
|
| RNA Interference | 13 | 2017 | 266 | 0.610 |
Why?
|
| Stem Cells | 2 | 2017 | 248 | 0.600 |
Why?
|
| Oxidative Stress | 10 | 2014 | 718 | 0.590 |
Why?
|
| Allosteric Site | 1 | 2017 | 17 | 0.590 |
Why?
|
| Phosphatidylserines | 12 | 2012 | 22 | 0.590 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 6 | 2004 | 15 | 0.580 |
Why?
|
| Research Design | 1 | 2021 | 729 | 0.580 |
Why?
|
| Biological Transport | 14 | 2018 | 210 | 0.580 |
Why?
|
| Protein Binding | 15 | 2017 | 1027 | 0.580 |
Why?
|
| Magnesium | 8 | 2012 | 110 | 0.570 |
Why?
|
| Azoxymethane | 3 | 2016 | 28 | 0.570 |
Why?
|
| Protein Kinases | 8 | 2000 | 122 | 0.570 |
Why?
|
| Recombinant Proteins | 20 | 2015 | 742 | 0.560 |
Why?
|
| Colon | 7 | 2017 | 168 | 0.550 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2016 | 3 | 0.550 |
Why?
|
| Gene Knockdown Techniques | 9 | 2015 | 196 | 0.540 |
Why?
|
| Cell Self Renewal | 1 | 2015 | 13 | 0.530 |
Why?
|
| Melanoma | 2 | 2021 | 335 | 0.530 |
Why?
|
| HCT116 Cells | 8 | 2021 | 63 | 0.530 |
Why?
|
| Histones | 2 | 2016 | 111 | 0.530 |
Why?
|
| Gene Deletion | 10 | 2020 | 235 | 0.520 |
Why?
|
| Cell Compartmentation | 5 | 2017 | 41 | 0.520 |
Why?
|
| Disease Models, Animal | 14 | 2021 | 2550 | 0.520 |
Why?
|
| Cells, Cultured | 23 | 2021 | 2673 | 0.510 |
Why?
|
| Bacterial Proteins | 3 | 2014 | 245 | 0.500 |
Why?
|
| Glutathione | 3 | 2006 | 343 | 0.500 |
Why?
|
| Tandem Mass Spectrometry | 5 | 2019 | 139 | 0.490 |
Why?
|
| Ralstonia solanacearum | 1 | 2014 | 1 | 0.490 |
Why?
|
| HEK293 Cells | 7 | 2018 | 326 | 0.490 |
Why?
|
| Adenosine Monophosphate | 1 | 2014 | 41 | 0.480 |
Why?
|
| Drug Resistance, Fungal | 2 | 2013 | 8 | 0.470 |
Why?
|
| Base Sequence | 20 | 2013 | 1015 | 0.470 |
Why?
|
| Cell Differentiation | 16 | 2020 | 1034 | 0.470 |
Why?
|
| Carrier Proteins | 6 | 2007 | 597 | 0.460 |
Why?
|
| Mice, Inbred C57BL | 26 | 2021 | 2791 | 0.460 |
Why?
|
| Endoplasmic Reticulum | 7 | 2019 | 148 | 0.460 |
Why?
|
| Platelet Aggregation | 8 | 1992 | 127 | 0.460 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 17 | 2015 | 710 | 0.460 |
Why?
|
| Deoxycytidine | 4 | 2011 | 83 | 0.450 |
Why?
|
| Transcription, Genetic | 10 | 2016 | 562 | 0.450 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2008 | 216 | 0.440 |
Why?
|
| Phorbol Esters | 12 | 2004 | 37 | 0.440 |
Why?
|
| Prostatic Neoplasms | 11 | 2012 | 778 | 0.440 |
Why?
|
| Farber Lipogranulomatosis | 3 | 2022 | 5 | 0.440 |
Why?
|
| Chromatography, Liquid | 12 | 2022 | 120 | 0.440 |
Why?
|
| Gene Expression | 11 | 2021 | 770 | 0.440 |
Why?
|
| Adenocarcinoma | 7 | 2005 | 475 | 0.440 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 11 | 2017 | 67 | 0.440 |
Why?
|
| Alzheimer Disease | 3 | 2018 | 565 | 0.440 |
Why?
|
| Gene Expression Regulation | 14 | 2017 | 1293 | 0.430 |
Why?
|
| Phospholipases A | 8 | 2006 | 41 | 0.430 |
Why?
|
| Endopeptidases | 2 | 2010 | 52 | 0.430 |
Why?
|
| Thrombin | 10 | 2006 | 117 | 0.430 |
Why?
|
| Micelles | 14 | 2000 | 43 | 0.420 |
Why?
|
| Monocytes | 5 | 2021 | 210 | 0.410 |
Why?
|
| Receptors, Lysosphingolipid | 6 | 2015 | 63 | 0.410 |
Why?
|
| Cloning, Molecular | 11 | 2008 | 357 | 0.410 |
Why?
|
| Mice, Nude | 7 | 2019 | 294 | 0.410 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2012 | 2 | 0.410 |
Why?
|
| L-Serine Dehydratase | 1 | 2012 | 1 | 0.410 |
Why?
|
| Lung | 5 | 2014 | 849 | 0.410 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2021 | 214 | 0.410 |
Why?
|
| Ultraviolet Rays | 4 | 2011 | 130 | 0.400 |
Why?
|
| Calcitriol | 6 | 1994 | 106 | 0.400 |
Why?
|
| Genetic Therapy | 8 | 2012 | 291 | 0.400 |
Why?
|
| Green Fluorescent Proteins | 10 | 2007 | 200 | 0.400 |
Why?
|
| Female | 39 | 2021 | 38074 | 0.400 |
Why?
|
| Feedback, Physiological | 1 | 2012 | 38 | 0.400 |
Why?
|
| Macrophages | 7 | 2020 | 647 | 0.400 |
Why?
|
| Binding Sites | 12 | 2018 | 631 | 0.400 |
Why?
|
| Plasmids | 8 | 2018 | 258 | 0.400 |
Why?
|
| Heat-Shock Response | 3 | 2015 | 7 | 0.400 |
Why?
|
| Cytokines | 7 | 2020 | 866 | 0.390 |
Why?
|
| Cysteine Endopeptidases | 7 | 2016 | 39 | 0.390 |
Why?
|
| Phorbol 12,13-Dibutyrate | 16 | 2000 | 24 | 0.390 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2011 | 17 | 0.390 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2009 | 109 | 0.380 |
Why?
|
| Luminescent Proteins | 7 | 2004 | 57 | 0.380 |
Why?
|
| Lipopolysaccharides | 5 | 2016 | 455 | 0.380 |
Why?
|
| Threonine | 2 | 2007 | 47 | 0.370 |
Why?
|
| Sequence Alignment | 7 | 2015 | 165 | 0.370 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2012 | 411 | 0.370 |
Why?
|
| Cytosol | 13 | 2008 | 123 | 0.370 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2021 | 331 | 0.360 |
Why?
|
| Endothelial Cells | 2 | 2015 | 384 | 0.360 |
Why?
|
| Protein Precursors | 1 | 2010 | 105 | 0.360 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2016 | 235 | 0.360 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2013 | 320 | 0.360 |
Why?
|
| RNA Stability | 1 | 2010 | 55 | 0.360 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2010 | 9 | 0.360 |
Why?
|
| Interleukin-1beta | 1 | 2010 | 88 | 0.360 |
Why?
|
| Mutagenesis | 5 | 2015 | 60 | 0.350 |
Why?
|
| Cytoskeleton | 3 | 2008 | 84 | 0.350 |
Why?
|
| Isotope Labeling | 2 | 2000 | 30 | 0.350 |
Why?
|
| Fungal Proteins | 4 | 2013 | 37 | 0.350 |
Why?
|
| Promoter Regions, Genetic | 8 | 2016 | 615 | 0.350 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2021 | 194 | 0.340 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 11 | 2005 | 272 | 0.340 |
Why?
|
| Intestinal Mucosa | 5 | 2017 | 219 | 0.340 |
Why?
|
| Carcinoma | 1 | 2011 | 215 | 0.340 |
Why?
|
| Drug Screening Assays, Antitumor | 5 | 2021 | 111 | 0.340 |
Why?
|
| Niemann-Pick Diseases | 4 | 2014 | 6 | 0.340 |
Why?
|
| Alternative Splicing | 3 | 2002 | 93 | 0.340 |
Why?
|
| Okadaic Acid | 9 | 2012 | 22 | 0.330 |
Why?
|
| Cyclooxygenase 2 | 9 | 2012 | 160 | 0.330 |
Why?
|
| Membrane Lipids | 6 | 2008 | 31 | 0.330 |
Why?
|
| G2 Phase | 1 | 2009 | 26 | 0.330 |
Why?
|
| Carcinogens | 4 | 2011 | 86 | 0.330 |
Why?
|
| Reactive Oxygen Species | 7 | 2021 | 499 | 0.330 |
Why?
|
| Glycerides | 6 | 1989 | 18 | 0.330 |
Why?
|
| Autophagy | 4 | 2021 | 208 | 0.320 |
Why?
|
| Helplessness, Learned | 1 | 2008 | 9 | 0.320 |
Why?
|
| Neoplasm Invasiveness | 8 | 2015 | 369 | 0.320 |
Why?
|
| Escherichia coli | 6 | 2015 | 368 | 0.320 |
Why?
|
| Pseudopodia | 3 | 2021 | 16 | 0.320 |
Why?
|
| Fenretinide | 4 | 2012 | 26 | 0.310 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 3 | 2004 | 73 | 0.310 |
Why?
|
| Hepatic Stellate Cells | 2 | 2020 | 53 | 0.310 |
Why?
|
| Financing, Organized | 1 | 2008 | 21 | 0.310 |
Why?
|
| Peer Review, Research | 1 | 2008 | 21 | 0.310 |
Why?
|
| Sequence Homology, Amino Acid | 7 | 2015 | 231 | 0.310 |
Why?
|
| Male | 43 | 2021 | 37321 | 0.300 |
Why?
|
| Amino Acid Substitution | 6 | 2011 | 137 | 0.300 |
Why?
|
| Liver | 9 | 2017 | 1118 | 0.300 |
Why?
|
| Antineoplastic Agents, Phytogenic | 6 | 2005 | 88 | 0.300 |
Why?
|
| Cellular Senescence | 5 | 2021 | 112 | 0.300 |
Why?
|
| Mammals | 4 | 2019 | 47 | 0.300 |
Why?
|
| Carcinogenesis | 3 | 2021 | 124 | 0.300 |
Why?
|
| Etoposide | 7 | 2004 | 64 | 0.300 |
Why?
|
| Cardiolipins | 2 | 2004 | 12 | 0.300 |
Why?
|
| Antidepressive Agents, Tricyclic | 3 | 2017 | 45 | 0.290 |
Why?
|
| Immunoblotting | 7 | 2013 | 254 | 0.290 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2021 | 78 | 0.290 |
Why?
|
| DNA Primers | 10 | 2007 | 302 | 0.290 |
Why?
|
| Carboxylic Acids | 3 | 2002 | 24 | 0.290 |
Why?
|
| Mutagenesis, Site-Directed | 7 | 2011 | 204 | 0.290 |
Why?
|
| Pseudomonas | 1 | 2006 | 8 | 0.290 |
Why?
|
| Enzyme Induction | 4 | 2016 | 119 | 0.280 |
Why?
|
| Desipramine | 4 | 2014 | 47 | 0.280 |
Why?
|
| Gene Regulatory Networks | 2 | 2020 | 94 | 0.280 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 2077 | 0.280 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2009 | 133 | 0.280 |
Why?
|
| Gene Silencing | 5 | 2017 | 137 | 0.280 |
Why?
|
| Acute Kidney Injury | 2 | 2022 | 232 | 0.280 |
Why?
|
| Blood Vessels | 3 | 2007 | 102 | 0.280 |
Why?
|
| Protein Conformation | 3 | 2019 | 362 | 0.280 |
Why?
|
| Acyltransferases | 4 | 2001 | 40 | 0.280 |
Why?
|
| Receptors, Cell Surface | 5 | 2000 | 248 | 0.280 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2006 | 45 | 0.280 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2006 | 52 | 0.280 |
Why?
|
| Cysteine | 1 | 2007 | 112 | 0.280 |
Why?
|
| Ovarian Neoplasms | 2 | 2021 | 267 | 0.280 |
Why?
|
| Respiratory Mucosa | 1 | 2006 | 52 | 0.280 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 236 | 0.270 |
Why?
|
| Phosphatidylcholines | 7 | 2012 | 38 | 0.270 |
Why?
|
| Colitis, Ulcerative | 3 | 2017 | 53 | 0.270 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 4 | 2013 | 95 | 0.270 |
Why?
|
| Carbazoles | 2 | 2017 | 46 | 0.270 |
Why?
|
| Crystallography, X-Ray | 2 | 2017 | 190 | 0.260 |
Why?
|
| fas Receptor | 4 | 2005 | 54 | 0.260 |
Why?
|
| Epidermal Growth Factor | 3 | 2015 | 95 | 0.260 |
Why?
|
| Transcription Factors | 5 | 2010 | 753 | 0.260 |
Why?
|
| Genes, Fungal | 4 | 2020 | 24 | 0.260 |
Why?
|
| Mitochondrial Membranes | 4 | 2014 | 45 | 0.260 |
Why?
|
| Insulin Resistance | 4 | 2018 | 241 | 0.260 |
Why?
|
| Fatty Acids | 3 | 2021 | 222 | 0.260 |
Why?
|
| Biomedical Research | 1 | 2009 | 310 | 0.260 |
Why?
|
| Benzylidene Compounds | 3 | 2017 | 16 | 0.260 |
Why?
|
| Receptors, Nerve Growth Factor | 2 | 1995 | 20 | 0.250 |
Why?
|
| Diet, High-Fat | 3 | 2021 | 81 | 0.250 |
Why?
|
| Aniline Compounds | 3 | 2017 | 52 | 0.250 |
Why?
|
| Kidney | 3 | 2006 | 945 | 0.250 |
Why?
|
| Mice, Transgenic | 8 | 2017 | 1033 | 0.250 |
Why?
|
| Phosphatidylglycerols | 1 | 2004 | 8 | 0.250 |
Why?
|
| Hippocampus | 1 | 2008 | 471 | 0.250 |
Why?
|
| Disease Progression | 4 | 2017 | 1038 | 0.250 |
Why?
|
| Palmitates | 3 | 2018 | 20 | 0.250 |
Why?
|
| Platelet Activation | 5 | 2006 | 24 | 0.250 |
Why?
|
| Cyclopentanes | 2 | 1996 | 15 | 0.240 |
Why?
|
| Subcellular Fractions | 5 | 2012 | 92 | 0.240 |
Why?
|
| Biological Transport, Active | 2 | 2017 | 49 | 0.240 |
Why?
|
| Arabidopsis | 3 | 2014 | 20 | 0.240 |
Why?
|
| Poly(ADP-ribose) Polymerases | 9 | 2001 | 39 | 0.230 |
Why?
|
| Allosteric Regulation | 4 | 2019 | 58 | 0.230 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2003 | 89 | 0.230 |
Why?
|
| Cathepsin B | 3 | 2012 | 33 | 0.230 |
Why?
|
| Platelet Activating Factor | 3 | 1999 | 34 | 0.230 |
Why?
|
| Glucosyltransferases | 4 | 2017 | 28 | 0.230 |
Why?
|
| Bone and Bones | 3 | 2014 | 145 | 0.230 |
Why?
|
| Telomerase | 6 | 2005 | 85 | 0.230 |
Why?
|
| Membrane Glycoproteins | 4 | 2014 | 370 | 0.220 |
Why?
|
| Systems Biology | 3 | 2013 | 25 | 0.220 |
Why?
|
| Computer Simulation | 3 | 2011 | 706 | 0.220 |
Why?
|
| Zinc | 3 | 2022 | 73 | 0.220 |
Why?
|
| Drug Resistance | 2 | 2015 | 223 | 0.220 |
Why?
|
| Genetic Vectors | 8 | 2012 | 312 | 0.220 |
Why?
|
| Gene Knockout Techniques | 3 | 2013 | 61 | 0.220 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2015 | 85 | 0.220 |
Why?
|
| Fatty Acids, Monounsaturated | 4 | 2017 | 29 | 0.220 |
Why?
|
| bcl-2-Associated X Protein | 5 | 2010 | 111 | 0.220 |
Why?
|
| Phosphoproteins | 3 | 1994 | 202 | 0.210 |
Why?
|
| Actins | 4 | 2011 | 249 | 0.210 |
Why?
|
| Mitochondrial Proteins | 4 | 2012 | 113 | 0.210 |
Why?
|
| Drug Synergism | 5 | 2017 | 260 | 0.210 |
Why?
|
| Protein-Tyrosine Kinases | 4 | 2013 | 195 | 0.210 |
Why?
|
| High-Throughput Screening Assays | 2 | 2020 | 48 | 0.210 |
Why?
|
| Amino Acids | 2 | 2019 | 131 | 0.210 |
Why?
|
| Phosphorylcholine | 3 | 2003 | 12 | 0.210 |
Why?
|
| Arachidonic Acids | 4 | 2009 | 97 | 0.210 |
Why?
|
| Dietary Fats | 2 | 2021 | 103 | 0.210 |
Why?
|
| Protein Folding | 2 | 2017 | 82 | 0.210 |
Why?
|
| Polyethylene Glycols | 6 | 1994 | 149 | 0.210 |
Why?
|
| Cisplatin | 3 | 2022 | 192 | 0.210 |
Why?
|
| Epithelial Cells | 5 | 2008 | 431 | 0.210 |
Why?
|
| Drug Design | 3 | 2014 | 107 | 0.210 |
Why?
|
| DNA-Binding Proteins | 7 | 2011 | 700 | 0.200 |
Why?
|
| Ions | 3 | 2010 | 50 | 0.200 |
Why?
|
| Bridged-Ring Compounds | 4 | 2004 | 14 | 0.200 |
Why?
|
| Brefeldin A | 6 | 2021 | 11 | 0.200 |
Why?
|
| Drug Discovery | 2 | 2020 | 94 | 0.200 |
Why?
|
| Thiones | 4 | 2004 | 16 | 0.200 |
Why?
|
| B-Lymphocytes | 2 | 2020 | 329 | 0.200 |
Why?
|
| Leukemia | 5 | 2012 | 117 | 0.200 |
Why?
|
| Group II Phospholipases A2 | 1 | 2021 | 6 | 0.200 |
Why?
|
| Collagen | 6 | 2017 | 636 | 0.200 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2021 | 12 | 0.200 |
Why?
|
| Carbon | 2 | 2015 | 122 | 0.200 |
Why?
|
| Education, Graduate | 1 | 2021 | 30 | 0.200 |
Why?
|
| Phosphatidylinositols | 5 | 2012 | 40 | 0.190 |
Why?
|
| Phosphates | 3 | 2018 | 72 | 0.190 |
Why?
|
| Retroviridae Infections | 1 | 2021 | 7 | 0.190 |
Why?
|
| Eukaryotic Cells | 1 | 2001 | 7 | 0.190 |
Why?
|
| Cysteine Proteinase Inhibitors | 3 | 1999 | 73 | 0.190 |
Why?
|
| Yeasts | 4 | 2014 | 15 | 0.190 |
Why?
|
| Milk | 1 | 2021 | 43 | 0.190 |
Why?
|
| Depression | 1 | 2008 | 943 | 0.190 |
Why?
|
| Tumor Virus Infections | 1 | 2021 | 32 | 0.190 |
Why?
|
| Coenzyme A | 1 | 2001 | 4 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2006 | 90 | 0.190 |
Why?
|
| HT29 Cells | 2 | 2018 | 42 | 0.190 |
Why?
|
| Glucose | 3 | 2014 | 307 | 0.190 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2020 | 116 | 0.190 |
Why?
|
| Heme Oxygenase-1 | 1 | 2021 | 40 | 0.190 |
Why?
|
| Intracellular Space | 2 | 2011 | 42 | 0.190 |
Why?
|
| Immune System | 2 | 2018 | 63 | 0.190 |
Why?
|
| Microscopy, Fluorescence | 7 | 2015 | 261 | 0.190 |
Why?
|
| Biomarkers, Tumor | 2 | 2019 | 508 | 0.190 |
Why?
|
| Octoxynol | 7 | 2000 | 19 | 0.190 |
Why?
|
| Genes, ras | 1 | 2021 | 46 | 0.190 |
Why?
|
| In Vitro Techniques | 10 | 2006 | 765 | 0.180 |
Why?
|
| Cross-Linking Reagents | 1 | 2001 | 80 | 0.180 |
Why?
|
| Detergents | 5 | 2000 | 34 | 0.180 |
Why?
|
| Fatty Acids, Nonesterified | 3 | 2014 | 48 | 0.180 |
Why?
|
| Acetic Acid | 2 | 2018 | 14 | 0.180 |
Why?
|
| Chromosome Segregation | 1 | 2020 | 3 | 0.180 |
Why?
|
| Oleic Acid | 4 | 1994 | 40 | 0.180 |
Why?
|
| Proteolysis | 1 | 2021 | 97 | 0.180 |
Why?
|
| Spindle Apparatus | 1 | 2020 | 13 | 0.180 |
Why?
|
| Prognosis | 3 | 2021 | 2093 | 0.180 |
Why?
|
| Chromosomes, Fungal | 1 | 2020 | 14 | 0.180 |
Why?
|
| Immunoprecipitation | 2 | 2013 | 132 | 0.180 |
Why?
|
| Arthritis, Experimental | 1 | 2020 | 38 | 0.180 |
Why?
|
| Plant Proteins | 2 | 2012 | 48 | 0.180 |
Why?
|
| Chromatography, Ion Exchange | 5 | 1999 | 73 | 0.180 |
Why?
|
| Cytochromes c | 7 | 2008 | 75 | 0.180 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2020 | 77 | 0.180 |
Why?
|
| Organ Specificity | 3 | 2015 | 167 | 0.180 |
Why?
|
| Antigen Presentation | 1 | 2020 | 76 | 0.180 |
Why?
|
| Vascular Diseases | 1 | 2020 | 94 | 0.180 |
Why?
|
| Atherosclerosis | 3 | 2018 | 204 | 0.180 |
Why?
|
| Neoplastic Stem Cells | 1 | 2020 | 84 | 0.180 |
Why?
|
| Cell Communication | 2 | 2020 | 116 | 0.170 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2020 | 268 | 0.170 |
Why?
|
| Radioisotopes | 1 | 2000 | 40 | 0.170 |
Why?
|
| Saposins | 2 | 2010 | 24 | 0.170 |
Why?
|
| RNA, Long Noncoding | 1 | 2020 | 54 | 0.170 |
Why?
|
| Placenta | 1 | 2020 | 101 | 0.170 |
Why?
|
| Fas Ligand Protein | 4 | 2008 | 64 | 0.170 |
Why?
|
| Adaptation, Physiological | 1 | 2021 | 189 | 0.170 |
Why?
|
| Mice, Mutant Strains | 3 | 2015 | 166 | 0.170 |
Why?
|
| Hypoxia | 1 | 2020 | 169 | 0.170 |
Why?
|
| Genes, myc | 3 | 2001 | 26 | 0.170 |
Why?
|
| Molecular Docking Simulation | 2 | 2021 | 78 | 0.170 |
Why?
|
| Pyridinium Compounds | 3 | 2010 | 40 | 0.170 |
Why?
|
| DNA Replication | 2 | 2018 | 167 | 0.170 |
Why?
|
| Students | 1 | 2021 | 233 | 0.170 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2015 | 167 | 0.170 |
Why?
|
| T-Lymphocytes | 5 | 2021 | 597 | 0.170 |
Why?
|
| Scattering, Small Angle | 1 | 2019 | 10 | 0.170 |
Why?
|
| Conserved Sequence | 3 | 2006 | 67 | 0.170 |
Why?
|
| Hemolysis | 2 | 2009 | 39 | 0.170 |
Why?
|
| Phenotype | 5 | 2013 | 947 | 0.170 |
Why?
|
| Molecular Probes | 1 | 2019 | 27 | 0.170 |
Why?
|
| Chemokine CCL2 | 2 | 2018 | 101 | 0.170 |
Why?
|
| Desmosomes | 1 | 2019 | 14 | 0.160 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 2 | 2012 | 65 | 0.160 |
Why?
|
| X-Ray Diffraction | 1 | 2019 | 53 | 0.160 |
Why?
|
| Nervous System | 1 | 2019 | 45 | 0.160 |
Why?
|
| Transplantation, Heterologous | 1 | 2019 | 122 | 0.160 |
Why?
|
| Cations | 6 | 2011 | 51 | 0.160 |
Why?
|
| Spectrum Analysis | 1 | 2019 | 81 | 0.160 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 266 | 0.160 |
Why?
|
| Autoimmune Diseases | 1 | 2020 | 186 | 0.160 |
Why?
|
| Cryptococcus neoformans | 3 | 2004 | 24 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-raf | 3 | 2005 | 20 | 0.160 |
Why?
|
| Intestines | 2 | 2010 | 114 | 0.160 |
Why?
|
| Palmitoyl Coenzyme A | 2 | 2011 | 11 | 0.160 |
Why?
|
| Naphthalenes | 4 | 2004 | 47 | 0.160 |
Why?
|
| Transformation, Genetic | 1 | 1998 | 14 | 0.160 |
Why?
|
| Mutation, Missense | 2 | 2011 | 112 | 0.160 |
Why?
|
| Hemorrhage | 1 | 2020 | 328 | 0.160 |
Why?
|
| Phagocytosis | 2 | 2012 | 65 | 0.160 |
Why?
|
| Flow Cytometry | 8 | 2020 | 489 | 0.160 |
Why?
|
| 3T3 Cells | 7 | 2011 | 124 | 0.160 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2018 | 4 | 0.160 |
Why?
|
| Intracellular Membranes | 3 | 2006 | 86 | 0.160 |
Why?
|
| Reperfusion Injury | 4 | 2017 | 320 | 0.160 |
Why?
|
| Antifungal Agents | 2 | 2013 | 108 | 0.160 |
Why?
|
| Nerve Growth Factors | 2 | 1995 | 75 | 0.160 |
Why?
|
| Chromatography | 4 | 2003 | 47 | 0.160 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2018 | 57 | 0.160 |
Why?
|
| Enzyme Stability | 2 | 2013 | 30 | 0.150 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 2 | 2017 | 2 | 0.150 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 1995 | 100 | 0.150 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2018 | 4 | 0.150 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2018 | 10 | 0.150 |
Why?
|
| Hemostasis | 1 | 2018 | 32 | 0.150 |
Why?
|
| Catalysis | 4 | 2011 | 123 | 0.150 |
Why?
|
| Trypan Blue | 4 | 2004 | 24 | 0.150 |
Why?
|
| Aldehyde-Lyases | 1 | 1997 | 2 | 0.150 |
Why?
|
| Niemann-Pick Disease, Type C | 1 | 2017 | 1 | 0.150 |
Why?
|
| Purkinje Cells | 3 | 2015 | 18 | 0.150 |
Why?
|
| Matrix Metalloproteinase 2 | 3 | 2007 | 145 | 0.150 |
Why?
|
| Enzymes | 1 | 2017 | 25 | 0.150 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2012 | 175 | 0.150 |
Why?
|
| Macrophages, Peritoneal | 1 | 2017 | 67 | 0.150 |
Why?
|
| DNA Repair | 2 | 2016 | 127 | 0.150 |
Why?
|
| Sphingolipidoses | 2 | 2007 | 2 | 0.150 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2018 | 62 | 0.150 |
Why?
|
| Mitochondrial Dynamics | 1 | 2017 | 17 | 0.150 |
Why?
|
| Genes, bcl-2 | 1 | 1997 | 10 | 0.150 |
Why?
|
| Proteins | 5 | 2004 | 474 | 0.150 |
Why?
|
| Transferrin | 3 | 2006 | 94 | 0.150 |
Why?
|
| Cattle | 6 | 2017 | 475 | 0.150 |
Why?
|
| Gene Ontology | 2 | 2014 | 31 | 0.150 |
Why?
|
| Ethers, Cyclic | 6 | 1996 | 13 | 0.150 |
Why?
|
| Adenosine Triphosphatases | 1 | 2017 | 83 | 0.150 |
Why?
|
| Tissue Array Analysis | 1 | 2017 | 53 | 0.150 |
Why?
|
| Inositol | 2 | 2009 | 11 | 0.150 |
Why?
|
| Hair Follicle | 1 | 2017 | 37 | 0.150 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 37 | 0.150 |
Why?
|
| Lipid Droplets | 1 | 2017 | 4 | 0.150 |
Why?
|
| Guanidines | 1 | 2017 | 32 | 0.150 |
Why?
|
| Osteocalcin | 2 | 2014 | 37 | 0.140 |
Why?
|
| Neutrophils | 2 | 2017 | 204 | 0.140 |
Why?
|
| Mitogens | 2 | 2007 | 45 | 0.140 |
Why?
|
| GTP-Binding Proteins | 1 | 1998 | 231 | 0.140 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2017 | 27 | 0.140 |
Why?
|
| Tamoxifen | 1 | 2017 | 62 | 0.140 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2011 | 468 | 0.140 |
Why?
|
| Exosomes | 2 | 2014 | 44 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 7 | 2021 | 532 | 0.140 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2017 | 41 | 0.140 |
Why?
|
| Alopecia | 1 | 2017 | 45 | 0.140 |
Why?
|
| Adenoviridae | 7 | 2006 | 295 | 0.140 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 135 | 0.140 |
Why?
|
| rab GTP-Binding Proteins | 2 | 2009 | 15 | 0.140 |
Why?
|
| Chromatography, Gel | 4 | 1999 | 79 | 0.140 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2013 | 282 | 0.140 |
Why?
|
| Species Specificity | 2 | 2015 | 303 | 0.140 |
Why?
|
| Anticarcinogenic Agents | 1 | 1997 | 52 | 0.140 |
Why?
|
| Bacteria | 2 | 2009 | 193 | 0.140 |
Why?
|
| Capsid Proteins | 2 | 2006 | 27 | 0.140 |
Why?
|
| Breast | 1 | 2017 | 137 | 0.140 |
Why?
|
| Checkpoint Kinase 1 | 1 | 2016 | 6 | 0.140 |
Why?
|
| Colloids | 2 | 1986 | 43 | 0.140 |
Why?
|
| Cell-Derived Microparticles | 1 | 2016 | 5 | 0.140 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2016 | 4 | 0.140 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2017 | 68 | 0.140 |
Why?
|
| Microscopy, Electron | 7 | 2014 | 351 | 0.140 |
Why?
|
| DNA, Complementary | 4 | 2010 | 251 | 0.140 |
Why?
|
| Vascular Calcification | 1 | 2017 | 131 | 0.130 |
Why?
|
| Adipose Tissue | 4 | 2018 | 221 | 0.130 |
Why?
|
| Risk | 1 | 2017 | 563 | 0.130 |
Why?
|
| Mutation Accumulation | 1 | 2015 | 1 | 0.130 |
Why?
|
| Protein Stability | 2 | 2021 | 90 | 0.130 |
Why?
|
| Molecular Targeted Therapy | 2 | 2021 | 170 | 0.130 |
Why?
|
| Acetylation | 1 | 2016 | 94 | 0.130 |
Why?
|
| Carbon Radioisotopes | 3 | 2000 | 34 | 0.130 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2017 | 138 | 0.130 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2015 | 7 | 0.130 |
Why?
|
| Osteoblasts | 2 | 2014 | 99 | 0.130 |
Why?
|
| Viral Proteins | 1 | 1997 | 150 | 0.130 |
Why?
|
| Cerebellar Ataxia | 1 | 2015 | 8 | 0.130 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2017 | 317 | 0.130 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2015 | 27 | 0.130 |
Why?
|
| Sf9 Cells | 1 | 2015 | 3 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2020 | 447 | 0.130 |
Why?
|
| Hydroxamic Acids | 1 | 2016 | 84 | 0.130 |
Why?
|
| Receptors, Neuropeptide | 1 | 1995 | 22 | 0.130 |
Why?
|
| Spodoptera | 1 | 2015 | 21 | 0.130 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2015 | 6 | 0.130 |
Why?
|
| Keratinocytes | 2 | 2019 | 68 | 0.130 |
Why?
|
| Cell Wall | 2 | 2012 | 21 | 0.130 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2015 | 13 | 0.130 |
Why?
|
| Pyrazoles | 3 | 2013 | 190 | 0.130 |
Why?
|
| Transcriptional Activation | 1 | 2016 | 226 | 0.130 |
Why?
|
| Protein Structure, Secondary | 1 | 2015 | 136 | 0.130 |
Why?
|
| Immunity, Innate | 1 | 2016 | 156 | 0.130 |
Why?
|
| Microbial Viability | 2 | 2013 | 27 | 0.130 |
Why?
|
| Temperature | 4 | 2008 | 341 | 0.120 |
Why?
|
| Hematopoietic System | 1 | 2014 | 8 | 0.120 |
Why?
|
| Histone Deacetylases | 1 | 2016 | 99 | 0.120 |
Why?
|
| Serpins | 1 | 1997 | 205 | 0.120 |
Why?
|
| Caspase 7 | 3 | 2011 | 6 | 0.120 |
Why?
|
| Culture Media | 3 | 2009 | 155 | 0.120 |
Why?
|
| Tritium | 5 | 2000 | 101 | 0.120 |
Why?
|
| Microvessels | 1 | 2015 | 43 | 0.120 |
Why?
|
| Oligopeptides | 2 | 2014 | 152 | 0.120 |
Why?
|
| Central Nervous System | 2 | 2009 | 107 | 0.120 |
Why?
|
| DNA Methylation | 1 | 2016 | 193 | 0.120 |
Why?
|
| Sepharose | 3 | 2011 | 18 | 0.120 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2014 | 4 | 0.120 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 1991 | 373 | 0.120 |
Why?
|
| Ligands | 1 | 2015 | 317 | 0.120 |
Why?
|
| Immunity | 2 | 2021 | 67 | 0.120 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2014 | 59 | 0.120 |
Why?
|
| Adipocytes | 1 | 2014 | 88 | 0.120 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2015 | 110 | 0.120 |
Why?
|
| Norbornanes | 4 | 2004 | 8 | 0.110 |
Why?
|
| Erythrocytes | 3 | 2008 | 137 | 0.110 |
Why?
|
| Risk Assessment | 2 | 2021 | 2007 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2012 | 2083 | 0.110 |
Why?
|
| Thiocarbamates | 4 | 2004 | 20 | 0.110 |
Why?
|
| Caspase 3 | 6 | 2017 | 233 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2009 | 507 | 0.110 |
Why?
|
| Mutant Proteins | 2 | 2013 | 45 | 0.110 |
Why?
|
| Blotting, Northern | 5 | 2005 | 189 | 0.110 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2013 | 9 | 0.110 |
Why?
|
| Photochemotherapy | 1 | 2014 | 59 | 0.110 |
Why?
|
| Cell Extracts | 2 | 2004 | 21 | 0.110 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2015 | 145 | 0.110 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 206 | 0.110 |
Why?
|
| Chromatography, Agarose | 2 | 2006 | 3 | 0.110 |
Why?
|
| Eicosanoids | 4 | 2004 | 16 | 0.110 |
Why?
|
| DNA, Mitochondrial | 2 | 2016 | 84 | 0.110 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2013 | 80 | 0.110 |
Why?
|
| Ribonucleotide Reductases | 1 | 2013 | 9 | 0.110 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2013 | 20 | 0.110 |
Why?
|
| Brain Chemistry | 2 | 2012 | 173 | 0.110 |
Why?
|
| Sympathetic Nervous System | 1 | 2013 | 81 | 0.110 |
Why?
|
| Adiponectin | 1 | 2013 | 52 | 0.110 |
Why?
|
| Vesicular Transport Proteins | 1 | 2013 | 87 | 0.110 |
Why?
|
| CDC28 Protein Kinase, S cerevisiae | 2 | 2011 | 4 | 0.110 |
Why?
|
| Hyperglycemia | 1 | 2014 | 158 | 0.110 |
Why?
|
| Bone Development | 1 | 2013 | 37 | 0.110 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 94 | 0.110 |
Why?
|
| Leukocytosis | 1 | 2012 | 13 | 0.110 |
Why?
|
| Rabbits | 4 | 2007 | 509 | 0.110 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 4 | 1994 | 11 | 0.110 |
Why?
|
| Nitric Oxide | 2 | 2012 | 382 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2006 | 376 | 0.100 |
Why?
|
| Isoquinolines | 4 | 1994 | 37 | 0.100 |
Why?
|
| Copper | 1 | 2014 | 149 | 0.100 |
Why?
|
| Protein Phosphatase 2C | 1 | 2012 | 3 | 0.100 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2009 | 32 | 0.100 |
Why?
|
| Lipoproteins, LDL | 2 | 2012 | 343 | 0.100 |
Why?
|
| Dependovirus | 1 | 2012 | 34 | 0.100 |
Why?
|
| Psychosine | 2 | 2010 | 33 | 0.100 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2021 | 69 | 0.100 |
Why?
|
| Veratrum Alkaloids | 1 | 2012 | 3 | 0.100 |
Why?
|
| Defensins | 1 | 2012 | 3 | 0.100 |
Why?
|
| Septins | 1 | 2012 | 3 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2014 | 163 | 0.100 |
Why?
|
| Metabolomics | 1 | 2012 | 28 | 0.100 |
Why?
|
| Bone Density | 1 | 2013 | 159 | 0.100 |
Why?
|
| AIDS Arteritis, Central Nervous System | 1 | 2012 | 1 | 0.100 |
Why?
|
| Risk Factors | 2 | 2021 | 5731 | 0.100 |
Why?
|
| Crohn Disease | 1 | 2012 | 38 | 0.100 |
Why?
|
| Ergosterol | 1 | 2011 | 3 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 290 | 0.100 |
Why?
|
| Candida albicans | 1 | 2012 | 39 | 0.100 |
Why?
|
| Astrocytes | 1 | 1994 | 270 | 0.100 |
Why?
|
| Hedgehog Proteins | 1 | 2012 | 38 | 0.100 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 306 | 0.100 |
Why?
|
| Liver Regeneration | 1 | 1992 | 38 | 0.100 |
Why?
|
| Encephalitis | 1 | 2012 | 43 | 0.100 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 1991 | 84 | 0.100 |
Why?
|
| Serotonin | 2 | 2009 | 144 | 0.100 |
Why?
|
| Leukemia, Promyelocytic, Acute | 5 | 1994 | 17 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 2 | 2015 | 183 | 0.100 |
Why?
|
| Thiazoles | 4 | 2007 | 95 | 0.100 |
Why?
|
| Calcification, Physiologic | 1 | 2011 | 31 | 0.100 |
Why?
|
| Energy Metabolism | 2 | 2013 | 222 | 0.100 |
Why?
|
| Thromboembolism | 1 | 2012 | 91 | 0.100 |
Why?
|
| ras Proteins | 1 | 2012 | 102 | 0.100 |
Why?
|
| Esterases | 2 | 2008 | 9 | 0.100 |
Why?
|
| Polyribosomes | 1 | 2011 | 24 | 0.100 |
Why?
|
| Imino Pyranoses | 1 | 2011 | 4 | 0.100 |
Why?
|
| Microsomes, Liver | 1 | 2011 | 44 | 0.100 |
Why?
|
| Precipitin Tests | 4 | 2003 | 88 | 0.100 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2011 | 16 | 0.100 |
Why?
|
| Insulin | 1 | 2014 | 619 | 0.100 |
Why?
|
| Caloric Restriction | 1 | 2011 | 22 | 0.100 |
Why?
|
| Transforming Growth Factor beta | 2 | 2004 | 384 | 0.090 |
Why?
|
| Membrane Potentials | 4 | 2007 | 200 | 0.090 |
Why?
|
| Immunohistochemistry | 5 | 2017 | 1174 | 0.090 |
Why?
|
| Combinatorial Chemistry Techniques | 2 | 2007 | 25 | 0.090 |
Why?
|
| Myelin Basic Protein | 2 | 2002 | 62 | 0.090 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 2 | 2008 | 58 | 0.090 |
Why?
|
| Bacteroides | 1 | 2010 | 7 | 0.090 |
Why?
|
| Piperazines | 4 | 1994 | 206 | 0.090 |
Why?
|
| Lipofuscin | 1 | 2011 | 43 | 0.090 |
Why?
|
| Liver Neoplasms | 1 | 2014 | 334 | 0.090 |
Why?
|
| Brain Injuries | 1 | 2014 | 268 | 0.090 |
Why?
|
| Electron Transport Complex IV | 2 | 2014 | 33 | 0.090 |
Why?
|
| bcl-X Protein | 3 | 2011 | 36 | 0.090 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 3 | 1995 | 10 | 0.090 |
Why?
|
| Expressed Sequence Tags | 1 | 2010 | 12 | 0.090 |
Why?
|
| Extracellular Space | 1 | 2010 | 121 | 0.090 |
Why?
|
| Indicators and Reagents | 4 | 2007 | 63 | 0.090 |
Why?
|
| Biomarkers | 4 | 2019 | 1593 | 0.090 |
Why?
|
| COS Cells | 3 | 2011 | 155 | 0.090 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 1990 | 21 | 0.090 |
Why?
|
| Dibutyryl Cyclic GMP | 1 | 1989 | 4 | 0.090 |
Why?
|
| Body Weight | 2 | 2009 | 554 | 0.090 |
Why?
|
| Mitochondria, Liver | 1 | 2011 | 148 | 0.090 |
Why?
|
| Chromatography, Thin Layer | 2 | 2000 | 52 | 0.090 |
Why?
|
| Plants | 1 | 2009 | 26 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2011 | 1040 | 0.090 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2009 | 6 | 0.090 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2006 | 140 | 0.090 |
Why?
|
| Interferon-gamma | 1 | 1991 | 241 | 0.090 |
Why?
|
| Cyclic GMP | 1 | 1989 | 99 | 0.090 |
Why?
|
| Acylation | 3 | 2017 | 22 | 0.090 |
Why?
|
| Molecular Weight | 4 | 2000 | 358 | 0.090 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2009 | 7 | 0.090 |
Why?
|
| Myeloid-Derived Suppressor Cells | 2 | 2021 | 21 | 0.090 |
Why?
|
| Transcription Factor CHOP | 1 | 2009 | 28 | 0.090 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2009 | 9 | 0.090 |
Why?
|
| Simian virus 40 | 2 | 2000 | 24 | 0.090 |
Why?
|
| Aspirin | 1 | 1991 | 295 | 0.080 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2006 | 50 | 0.080 |
Why?
|
| Tetrazolium Salts | 3 | 2004 | 36 | 0.080 |
Why?
|
| Phospholipases A2 | 5 | 2003 | 32 | 0.080 |
Why?
|
| Disease | 1 | 2009 | 41 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 1996 | 1026 | 0.080 |
Why?
|
| Mesylates | 1 | 2009 | 5 | 0.080 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2009 | 48 | 0.080 |
Why?
|
| Coloring Agents | 3 | 2004 | 66 | 0.080 |
Why?
|
| Caspase Inhibitors | 4 | 2005 | 36 | 0.080 |
Why?
|
| Cell Count | 2 | 2004 | 248 | 0.080 |
Why?
|
| Cell Respiration | 1 | 2009 | 47 | 0.080 |
Why?
|
| Erythrocyte Membrane | 1 | 2008 | 20 | 0.080 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2008 | 27 | 0.080 |
Why?
|
| Microarray Analysis | 1 | 2009 | 63 | 0.080 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2008 | 35 | 0.080 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2009 | 32 | 0.080 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 142 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2009 | 183 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2015 | 250 | 0.080 |
Why?
|
| Spores, Fungal | 2 | 2006 | 4 | 0.080 |
Why?
|
| Oryza | 1 | 2008 | 12 | 0.080 |
Why?
|
| Organometallic Compounds | 1 | 1989 | 95 | 0.080 |
Why?
|
| Caspase 9 | 3 | 2006 | 31 | 0.080 |
Why?
|
| Cannabinoids | 1 | 2009 | 90 | 0.080 |
Why?
|
| Aminoacridines | 1 | 1988 | 1 | 0.080 |
Why?
|
| Adult | 10 | 2021 | 21403 | 0.080 |
Why?
|
| Oxidation-Reduction | 2 | 2007 | 567 | 0.080 |
Why?
|
| Circular Dichroism | 2 | 2006 | 99 | 0.080 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1999 | 107 | 0.080 |
Why?
|
| Pseudomonas Infections | 1 | 2009 | 83 | 0.080 |
Why?
|
| Enzyme Precursors | 2 | 1998 | 27 | 0.080 |
Why?
|
| Cell Line, Transformed | 2 | 2000 | 100 | 0.080 |
Why?
|
| Integrins | 1 | 2008 | 115 | 0.080 |
Why?
|
| Mycotoxins | 2 | 2000 | 5 | 0.080 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 2 | 2005 | 59 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2015 | 58 | 0.080 |
Why?
|
| Pyrimidines | 1 | 2009 | 178 | 0.080 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 213 | 0.080 |
Why?
|
| Myocardium | 3 | 2000 | 1204 | 0.080 |
Why?
|
| Sensitivity and Specificity | 4 | 2008 | 1753 | 0.070 |
Why?
|
| Biogenic Amines | 1 | 2007 | 15 | 0.070 |
Why?
|
| Monoamine Oxidase | 1 | 2007 | 26 | 0.070 |
Why?
|
| Gamma Rays | 3 | 2008 | 64 | 0.070 |
Why?
|
| HL-60 Cells | 4 | 2004 | 50 | 0.070 |
Why?
|
| Furin | 1 | 2007 | 3 | 0.070 |
Why?
|
| Random Allocation | 1 | 2008 | 442 | 0.070 |
Why?
|
| Protease Inhibitors | 2 | 2000 | 76 | 0.070 |
Why?
|
| Transgenes | 2 | 2006 | 92 | 0.070 |
Why?
|
| Vincristine | 3 | 1998 | 44 | 0.070 |
Why?
|
| Metabolic Syndrome | 1 | 2009 | 191 | 0.070 |
Why?
|
| Cadherins | 2 | 2004 | 93 | 0.070 |
Why?
|
| Tumor Burden | 2 | 2021 | 132 | 0.070 |
Why?
|
| Silver Staining | 2 | 2003 | 11 | 0.070 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2007 | 44 | 0.070 |
Why?
|
| Microtubules | 2 | 2005 | 104 | 0.070 |
Why?
|
| Survival Rate | 3 | 2021 | 1056 | 0.070 |
Why?
|
| Chromatography, Affinity | 2 | 1998 | 73 | 0.070 |
Why?
|
| Sulfoglycosphingolipids | 1 | 2006 | 8 | 0.070 |
Why?
|
| Hyaluronic Acid | 1 | 2008 | 206 | 0.070 |
Why?
|
| Feedback | 1 | 2006 | 90 | 0.070 |
Why?
|
| Blood Pressure | 1 | 2012 | 1451 | 0.070 |
Why?
|
| Propylene Glycols | 1 | 2006 | 16 | 0.070 |
Why?
|
| Potassium | 2 | 1997 | 168 | 0.070 |
Why?
|
| Choline | 2 | 2004 | 14 | 0.070 |
Why?
|
| Clathrin | 1 | 2006 | 17 | 0.070 |
Why?
|
| DNA Fragmentation | 2 | 2009 | 85 | 0.070 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2006 | 24 | 0.070 |
Why?
|
| Prostaglandins | 1 | 2006 | 65 | 0.070 |
Why?
|
| CD59 Antigens | 1 | 2006 | 30 | 0.070 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2006 | 8 | 0.070 |
Why?
|
| Animal Feed | 2 | 2021 | 52 | 0.070 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2021 | 73 | 0.070 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2009 | 51 | 0.070 |
Why?
|
| Consensus Sequence | 1 | 2006 | 20 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2008 | 304 | 0.070 |
Why?
|
| RNA, Fungal | 1 | 2006 | 6 | 0.070 |
Why?
|
| Jurkat Cells | 3 | 2003 | 59 | 0.070 |
Why?
|
| United States | 2 | 2009 | 7367 | 0.070 |
Why?
|
| Oncogene Protein v-akt | 1 | 2005 | 25 | 0.070 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2006 | 19 | 0.070 |
Why?
|
| Amino Acid Motifs | 1 | 2006 | 77 | 0.070 |
Why?
|
| Neuroblastoma | 1 | 2007 | 109 | 0.070 |
Why?
|
| Reproduction | 1 | 2006 | 48 | 0.070 |
Why?
|
| Obesity | 3 | 2009 | 1076 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2010 | 346 | 0.060 |
Why?
|
| Surface Plasmon Resonance | 1 | 2005 | 50 | 0.060 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2005 | 74 | 0.060 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 1996 | 70 | 0.060 |
Why?
|
| Animals, Newborn | 2 | 2004 | 396 | 0.060 |
Why?
|
| Coenzyme A Ligases | 2 | 2017 | 25 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 2 | 2012 | 247 | 0.060 |
Why?
|
| Receptor, trkA | 2 | 1995 | 13 | 0.060 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2005 | 100 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2018 | 114 | 0.060 |
Why?
|
| Metals | 1 | 2006 | 100 | 0.060 |
Why?
|
| Phospholipase C gamma | 2 | 2002 | 13 | 0.060 |
Why?
|
| CDPdiacylglycerol-Serine O-Phosphatidyltransferase | 1 | 2004 | 2 | 0.060 |
Why?
|
| Hep G2 Cells | 2 | 2016 | 68 | 0.060 |
Why?
|
| Microsomes | 2 | 2006 | 31 | 0.060 |
Why?
|
| Biochemical Phenomena | 1 | 2004 | 3 | 0.060 |
Why?
|
| Cyclic AMP | 1 | 2005 | 223 | 0.060 |
Why?
|
| Glycosylation | 2 | 2021 | 185 | 0.060 |
Why?
|
| Biochemistry | 1 | 2004 | 12 | 0.060 |
Why?
|
| Cystic Fibrosis | 1 | 2009 | 283 | 0.060 |
Why?
|
| Surface-Active Agents | 1 | 1985 | 57 | 0.060 |
Why?
|
| Genes, Reporter | 4 | 2006 | 191 | 0.060 |
Why?
|
| Cell Separation | 3 | 2014 | 132 | 0.060 |
Why?
|
| Genomics | 1 | 2005 | 168 | 0.060 |
Why?
|
| 1-Butanol | 1 | 2004 | 2 | 0.060 |
Why?
|
| Cytoplasm | 3 | 2008 | 155 | 0.060 |
Why?
|
| Luciferases | 4 | 2003 | 105 | 0.060 |
Why?
|
| Diabetes Mellitus | 2 | 2007 | 694 | 0.060 |
Why?
|
| Mice, 129 Strain | 2 | 2015 | 44 | 0.060 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 2004 | 9 | 0.060 |
Why?
|
| Zellweger Syndrome | 1 | 2004 | 14 | 0.060 |
Why?
|
| Holoenzymes | 1 | 2003 | 7 | 0.060 |
Why?
|
| Enzyme Activators | 1 | 2003 | 14 | 0.060 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (NADP+)(Phosphorylating) | 1 | 2003 | 4 | 0.060 |
Why?
|
| Antigens, Neoplasm | 1 | 2004 | 132 | 0.060 |
Why?
|
| Ubiquitins | 2 | 2001 | 22 | 0.060 |
Why?
|
| Pilot Projects | 1 | 2008 | 1342 | 0.060 |
Why?
|
| Nocodazole | 1 | 2003 | 11 | 0.060 |
Why?
|
| Models, Genetic | 3 | 2011 | 161 | 0.060 |
Why?
|
| Stimulation, Chemical | 2 | 1995 | 57 | 0.060 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2003 | 55 | 0.060 |
Why?
|
| Peroxisomes | 1 | 2004 | 48 | 0.060 |
Why?
|
| Ionophores | 1 | 2003 | 25 | 0.060 |
Why?
|
| Egtazic Acid | 4 | 1997 | 29 | 0.060 |
Why?
|
| Middle Aged | 6 | 2021 | 21147 | 0.060 |
Why?
|
| Durapatite | 2 | 1994 | 33 | 0.060 |
Why?
|
| Hepatocytes | 1 | 2005 | 205 | 0.060 |
Why?
|
| Maternal Deprivation | 1 | 2003 | 4 | 0.060 |
Why?
|
| RNA, Transfer | 1 | 2003 | 10 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2004 | 199 | 0.060 |
Why?
|
| Poly A | 2 | 1993 | 14 | 0.060 |
Why?
|
| Touch | 1 | 2003 | 25 | 0.050 |
Why?
|
| Dactinomycin | 2 | 2004 | 31 | 0.050 |
Why?
|
| Age Factors | 1 | 2008 | 1864 | 0.050 |
Why?
|
| Cathepsin D | 1 | 2002 | 13 | 0.050 |
Why?
|
| Multigene Family | 1 | 2003 | 93 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2003 | 50 | 0.050 |
Why?
|
| Chemokine CXCL1 | 2 | 2017 | 21 | 0.050 |
Why?
|
| Cell Fractionation | 2 | 1999 | 34 | 0.050 |
Why?
|
| Cell-Free System | 2 | 2005 | 43 | 0.050 |
Why?
|
| Chemokines | 2 | 2017 | 119 | 0.050 |
Why?
|
| 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid | 3 | 1997 | 4 | 0.050 |
Why?
|
| Bile Ducts | 2 | 2005 | 59 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 514 | 0.050 |
Why?
|
| Ethanol | 1 | 2009 | 893 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2007 | 561 | 0.050 |
Why?
|
| Oxidants | 2 | 2013 | 48 | 0.050 |
Why?
|
| Phosphorylase a | 1 | 2002 | 2 | 0.050 |
Why?
|
| Leukemia, T-Cell | 3 | 1999 | 21 | 0.050 |
Why?
|
| Deoxyglucose | 3 | 2016 | 32 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 498 | 0.050 |
Why?
|
| Bucladesine | 2 | 1992 | 8 | 0.050 |
Why?
|
| Marine Toxins | 1 | 2002 | 14 | 0.050 |
Why?
|
| Oxazoles | 1 | 2002 | 17 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2008 | 824 | 0.050 |
Why?
|
| Peptides | 4 | 2005 | 455 | 0.050 |
Why?
|
| Glioma | 2 | 1993 | 140 | 0.050 |
Why?
|
| Shiga Toxin | 1 | 2021 | 1 | 0.050 |
Why?
|
| Cholera Toxin | 1 | 2021 | 30 | 0.050 |
Why?
|
| Drug Resistance, Multiple | 1 | 2001 | 56 | 0.050 |
Why?
|
| Olive Oil | 1 | 2021 | 3 | 0.050 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2021 | 15 | 0.050 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2021 | 8 | 0.050 |
Why?
|
| THP-1 Cells | 1 | 2021 | 7 | 0.050 |
Why?
|
| Phosphorus Radioisotopes | 2 | 2000 | 29 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2013 | 219 | 0.050 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2001 | 22 | 0.050 |
Why?
|
| Oncogene Proteins | 1 | 2021 | 35 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2003 | 328 | 0.050 |
Why?
|
| Glycoside Hydrolases | 2 | 2011 | 25 | 0.050 |
Why?
|
| Autoantigens | 1 | 2021 | 91 | 0.050 |
Why?
|
| Rats, Inbred Strains | 3 | 1992 | 532 | 0.050 |
Why?
|
| Datasets as Topic | 1 | 2021 | 53 | 0.050 |
Why?
|
| Disease-Free Survival | 1 | 2021 | 349 | 0.050 |
Why?
|
| Dictyostelium | 1 | 2000 | 7 | 0.050 |
Why?
|
| HLA-DR4 Antigen | 1 | 2020 | 11 | 0.050 |
Why?
|
| Cyclins | 1 | 2000 | 50 | 0.050 |
Why?
|
| Mitochondria, Muscle | 1 | 2000 | 12 | 0.050 |
Why?
|
| Th1 Cells | 1 | 2021 | 101 | 0.050 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 91 | 0.050 |
Why?
|
| Heparin | 2 | 2010 | 205 | 0.050 |
Why?
|
| Laboratories | 1 | 2020 | 44 | 0.050 |
Why?
|
| Cathepsins | 1 | 2020 | 37 | 0.050 |
Why?
|
| Oxygen | 2 | 2021 | 386 | 0.050 |
Why?
|
| Blood | 1 | 2000 | 40 | 0.050 |
Why?
|
| Bayes Theorem | 2 | 2014 | 307 | 0.050 |
Why?
|
| Mice, Inbred DBA | 1 | 2020 | 120 | 0.050 |
Why?
|
| Antigen-Presenting Cells | 1 | 2020 | 50 | 0.050 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2021 | 87 | 0.040 |
Why?
|
| Leukemia, B-Cell | 2 | 1998 | 7 | 0.040 |
Why?
|
| Peptide Hydrolases | 1 | 2000 | 82 | 0.040 |
Why?
|
| Mitochondria, Heart | 1 | 2000 | 53 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2013 | 7277 | 0.040 |
Why?
|
| Autoradiography | 1 | 2000 | 94 | 0.040 |
Why?
|
| Glycerophospholipids | 1 | 2000 | 20 | 0.040 |
Why?
|
| Small Molecule Libraries | 1 | 2020 | 53 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 209 | 0.040 |
Why?
|
| Hydrogen Peroxide | 2 | 2013 | 168 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 371 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2013 | 223 | 0.040 |
Why?
|
| Leukocytes | 2 | 2006 | 99 | 0.040 |
Why?
|
| Potassium Channels | 2 | 1997 | 55 | 0.040 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 1999 | 8 | 0.040 |
Why?
|
| Osmolar Concentration | 1 | 1999 | 134 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 3 | 2009 | 492 | 0.040 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2000 | 103 | 0.040 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2004 | 43 | 0.040 |
Why?
|
| Desmogleins | 1 | 2019 | 4 | 0.040 |
Why?
|
| Permeability | 2 | 2012 | 131 | 0.040 |
Why?
|
| Cosmetics | 1 | 2019 | 5 | 0.040 |
Why?
|
| Intercellular Junctions | 1 | 2019 | 32 | 0.040 |
Why?
|
| Restriction Mapping | 2 | 2004 | 85 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2021 | 215 | 0.040 |
Why?
|
| Isoelectric Focusing | 1 | 1998 | 42 | 0.040 |
Why?
|
| Cations, Divalent | 1 | 1998 | 27 | 0.040 |
Why?
|
| Organelles | 1 | 1998 | 18 | 0.040 |
Why?
|
| Epidermis | 1 | 2019 | 42 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2020 | 226 | 0.040 |
Why?
|
| Algorithms | 1 | 2004 | 1196 | 0.040 |
Why?
|
| Mutagenicity Tests | 1 | 1998 | 5 | 0.040 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1998 | 19 | 0.040 |
Why?
|
| Child | 3 | 2021 | 6405 | 0.040 |
Why?
|
| Fibrosis | 1 | 2020 | 371 | 0.040 |
Why?
|
| Organ Size | 2 | 2009 | 242 | 0.040 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2018 | 15 | 0.040 |
Why?
|
| Thymidylate Synthase | 1 | 1998 | 42 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 1 | 1998 | 219 | 0.040 |
Why?
|
| Deuterium Exchange Measurement | 1 | 2018 | 2 | 0.040 |
Why?
|
| Quinazolines | 1 | 1998 | 70 | 0.040 |
Why?
|
| Organisms, Genetically Modified | 1 | 2017 | 2 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 4848 | 0.040 |
Why?
|
| Buthionine Sulfoximine | 1 | 1997 | 10 | 0.040 |
Why?
|
| Dithiothreitol | 1 | 1997 | 17 | 0.040 |
Why?
|
| trans-Golgi Network | 2 | 2007 | 3 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 1998 | 133 | 0.040 |
Why?
|
| Kidney Cortex | 1 | 2017 | 19 | 0.040 |
Why?
|
| Chemokine CXCL2 | 1 | 2017 | 13 | 0.040 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2017 | 2 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 1997 | 59 | 0.040 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 1997 | 4 | 0.040 |
Why?
|
| Oligonucleotide Probes | 2 | 1994 | 35 | 0.040 |
Why?
|
| A549 Cells | 1 | 2017 | 50 | 0.040 |
Why?
|
| Cannabinoid Receptor Antagonists | 1 | 2017 | 10 | 0.040 |
Why?
|
| Cannabinoid Receptor Agonists | 1 | 2017 | 20 | 0.040 |
Why?
|
| Transglutaminases | 1 | 1997 | 67 | 0.040 |
Why?
|
| Thromboxane B2 | 2 | 2003 | 108 | 0.040 |
Why?
|
| Guanosine Triphosphate | 2 | 1997 | 65 | 0.040 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 2 | 1995 | 13 | 0.040 |
Why?
|
| Protein Domains | 1 | 2017 | 74 | 0.040 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 1997 | 84 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 2 | 1994 | 48 | 0.040 |
Why?
|
| HIV-1 | 1 | 1998 | 177 | 0.040 |
Why?
|
| Troponin | 1 | 1996 | 25 | 0.030 |
Why?
|
| Paclitaxel | 2 | 2008 | 140 | 0.030 |
Why?
|
| Baculoviridae | 1 | 1996 | 14 | 0.030 |
Why?
|
| Polycyclic Compounds | 2 | 1994 | 5 | 0.030 |
Why?
|
| Myofibroblasts | 1 | 2017 | 60 | 0.030 |
Why?
|
| Biological Assay | 1 | 2017 | 88 | 0.030 |
Why?
|
| Caspase 2 | 1 | 2016 | 4 | 0.030 |
Why?
|
| Proto-Oncogenes | 1 | 1996 | 37 | 0.030 |
Why?
|
| M Phase Cell Cycle Checkpoints | 1 | 2016 | 2 | 0.030 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2016 | 28 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 1997 | 172 | 0.030 |
Why?
|
| Actin Cytoskeleton | 1 | 1996 | 37 | 0.030 |
Why?
|
| Macrolides | 1 | 1996 | 48 | 0.030 |
Why?
|
| Ion Channel Gating | 1 | 1996 | 42 | 0.030 |
Why?
|
| Cells | 1 | 1996 | 7 | 0.030 |
Why?
|
| Peptide Mapping | 2 | 1996 | 39 | 0.030 |
Why?
|
| Antimycin A | 1 | 2016 | 2 | 0.030 |
Why?
|
| Aged | 3 | 2021 | 14862 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2019 | 332 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 1851 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2012 | 1553 | 0.030 |
Why?
|
| Mice, SCID | 2 | 2007 | 238 | 0.030 |
Why?
|
| Receptor, trkC | 1 | 1995 | 6 | 0.030 |
Why?
|
| Neurotrophin 3 | 1 | 1995 | 7 | 0.030 |
Why?
|
| Linoleic Acids | 1 | 1995 | 12 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2016 | 93 | 0.030 |
Why?
|
| Transcription Factor DP1 | 1 | 1995 | 11 | 0.030 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 1995 | 15 | 0.030 |
Why?
|
| Mink | 1 | 1995 | 12 | 0.030 |
Why?
|
| Leukemia, Lymphoid | 1 | 1995 | 17 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2007 | 144 | 0.030 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1995 | 10 | 0.030 |
Why?
|
| Coumarins | 1 | 2015 | 7 | 0.030 |
Why?
|
| Eye Neoplasms | 1 | 1995 | 10 | 0.030 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 1995 | 19 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 1995 | 71 | 0.030 |
Why?
|
| Retinoblastoma | 1 | 1995 | 26 | 0.030 |
Why?
|
| Tissue Distribution | 2 | 2006 | 282 | 0.030 |
Why?
|
| Goblet Cells | 1 | 2015 | 9 | 0.030 |
Why?
|
| Autocrine Communication | 1 | 2015 | 37 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2015 | 94 | 0.030 |
Why?
|
| Adenovirus E1A Proteins | 1 | 1995 | 6 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2016 | 124 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2015 | 85 | 0.030 |
Why?
|
| E2F Transcription Factors | 1 | 1995 | 48 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2015 | 89 | 0.030 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2015 | 20 | 0.030 |
Why?
|
| Lymphatic Metastasis | 2 | 2007 | 274 | 0.030 |
Why?
|
| Electroretinography | 1 | 2015 | 122 | 0.030 |
Why?
|
| Feeding Behavior | 1 | 2017 | 224 | 0.030 |
Why?
|
| Bystander Effect | 2 | 2006 | 10 | 0.030 |
Why?
|
| Diethylnitrosamine | 1 | 2014 | 10 | 0.030 |
Why?
|
| Drug Combinations | 2 | 2006 | 304 | 0.030 |
Why?
|
| Genes, Regulator | 1 | 1994 | 17 | 0.030 |
Why?
|
| Alkylating Agents | 1 | 2014 | 15 | 0.030 |
Why?
|
| Wound Healing | 1 | 2017 | 260 | 0.030 |
Why?
|
| Esters | 1 | 2014 | 22 | 0.030 |
Why?
|
| 3T3-L1 Cells | 1 | 2014 | 30 | 0.030 |
Why?
|
| Melanoma, Experimental | 1 | 1995 | 95 | 0.030 |
Why?
|
| Pregnancy | 1 | 2020 | 2334 | 0.030 |
Why?
|
| PubMed | 1 | 2014 | 21 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 2014 | 69 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2015 | 144 | 0.030 |
Why?
|
| Sulfhydryl Reagents | 1 | 1994 | 6 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 1994 | 118 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 191 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2014 | 81 | 0.030 |
Why?
|
| U937 Cells | 2 | 2004 | 61 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 2014 | 134 | 0.030 |
Why?
|
| Glucose Intolerance | 1 | 2014 | 36 | 0.030 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2004 | 22 | 0.030 |
Why?
|
| Bone Resorption | 1 | 2014 | 64 | 0.030 |
Why?
|
| Receptor, Insulin | 1 | 2014 | 71 | 0.030 |
Why?
|
| Computational Biology | 1 | 2015 | 190 | 0.030 |
Why?
|
| Workflow | 1 | 2014 | 100 | 0.030 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1993 | 11 | 0.030 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2013 | 9 | 0.030 |
Why?
|
| Depsipeptides | 1 | 2013 | 21 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 1997 | 400 | 0.030 |
Why?
|
| Photoreceptor Cells | 1 | 1994 | 62 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 301 | 0.030 |
Why?
|
| Models, Animal | 1 | 2014 | 252 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 493 | 0.030 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1993 | 42 | 0.030 |
Why?
|
| I-kappa B Kinase | 1 | 2013 | 40 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 89 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2013 | 20 | 0.030 |
Why?
|
| Ribonucleases | 1 | 1993 | 25 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1993 | 72 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 244 | 0.030 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2013 | 34 | 0.030 |
Why?
|
| Adrenal Medulla | 1 | 1993 | 5 | 0.030 |
Why?
|
| Nucleosomes | 1 | 1993 | 25 | 0.030 |
Why?
|
| Myristoylated Alanine-Rich C Kinase Substrate | 1 | 1993 | 3 | 0.030 |
Why?
|
| Hydroxyapatites | 1 | 1993 | 10 | 0.030 |
Why?
|
| Acrolein | 1 | 1993 | 9 | 0.030 |
Why?
|
| Depression, Chemical | 1 | 1993 | 29 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2014 | 230 | 0.030 |
Why?
|
| Carmustine | 1 | 1993 | 14 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2013 | 226 | 0.030 |
Why?
|
| Vinblastine | 1 | 1993 | 40 | 0.030 |
Why?
|
| Ionomycin | 1 | 1992 | 24 | 0.030 |
Why?
|
| Prostaglandin-E Synthases | 1 | 2012 | 6 | 0.030 |
Why?
|
| RNA Probes | 1 | 1992 | 15 | 0.030 |
Why?
|
| Celecoxib | 1 | 2012 | 22 | 0.030 |
Why?
|
| Genomic Library | 1 | 1992 | 18 | 0.030 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2012 | 10 | 0.030 |
Why?
|
| Isomerism | 1 | 1992 | 63 | 0.030 |
Why?
|
| Locus Coeruleus | 1 | 2013 | 55 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 1993 | 76 | 0.030 |
Why?
|
| Leptin | 1 | 2013 | 80 | 0.030 |
Why?
|
| Caspase 8 | 2 | 2005 | 40 | 0.030 |
Why?
|
| Iron | 1 | 1994 | 197 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2012 | 45 | 0.030 |
Why?
|
| Epoprostenol | 1 | 2012 | 71 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 1992 | 88 | 0.030 |
Why?
|
| Leukemia, Myeloid | 1 | 1992 | 39 | 0.030 |
Why?
|
| Ileum | 1 | 2012 | 28 | 0.030 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2012 | 46 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 1993 | 129 | 0.030 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1992 | 63 | 0.030 |
Why?
|
| Endotoxins | 1 | 2012 | 76 | 0.030 |
Why?
|
| Masoprocol | 1 | 2012 | 3 | 0.030 |
Why?
|
| Flavanones | 1 | 2012 | 6 | 0.030 |
Why?
|
| Hyphae | 1 | 2012 | 4 | 0.030 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 2012 | 9 | 0.030 |
Why?
|
| Raphanus | 1 | 2012 | 2 | 0.030 |
Why?
|
| Virulence | 2 | 2003 | 51 | 0.030 |
Why?
|
| Trans-Activators | 2 | 2004 | 237 | 0.030 |
Why?
|
| Smoothened Receptor | 1 | 2012 | 10 | 0.030 |
Why?
|
| Nuclear Envelope | 1 | 1992 | 8 | 0.030 |
Why?
|
| RNA | 1 | 1993 | 171 | 0.030 |
Why?
|
| Ascorbic Acid | 1 | 2012 | 45 | 0.030 |
Why?
|
| Vitamin E | 1 | 2012 | 55 | 0.030 |
Why?
|
| Transcriptome | 1 | 2013 | 164 | 0.030 |
Why?
|
| Biology | 1 | 2012 | 14 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2012 | 94 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 127 | 0.020 |
Why?
|
| Angiotensin II | 1 | 1993 | 220 | 0.020 |
Why?
|
| Methyl Methanesulfonate | 1 | 2011 | 7 | 0.020 |
Why?
|
| Chitin | 1 | 2011 | 6 | 0.020 |
Why?
|
| Mutagens | 1 | 2011 | 18 | 0.020 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2011 | 12 | 0.020 |
Why?
|
| Glioblastoma | 1 | 1994 | 219 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2012 | 141 | 0.020 |
Why?
|
| Pertussis Toxin | 2 | 2005 | 72 | 0.020 |
Why?
|
| Palmitoyl-CoA Hydrolase | 1 | 2011 | 3 | 0.020 |
Why?
|
| Peptaibols | 1 | 2011 | 3 | 0.020 |
Why?
|
| Platelet Count | 1 | 1991 | 100 | 0.020 |
Why?
|
| Chondrocytes | 1 | 2011 | 27 | 0.020 |
Why?
|
| Demography | 1 | 2012 | 279 | 0.020 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2011 | 4 | 0.020 |
Why?
|
| Chromatin | 2 | 2003 | 76 | 0.020 |
Why?
|
| Adolescent | 2 | 2021 | 8912 | 0.020 |
Why?
|
| Pyridines | 1 | 2013 | 261 | 0.020 |
Why?
|
| Reducing Agents | 1 | 2011 | 5 | 0.020 |
Why?
|
| Blood Proteins | 1 | 1991 | 94 | 0.020 |
Why?
|
| Young Adult | 2 | 2013 | 5717 | 0.020 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2010 | 24 | 0.020 |
Why?
|
| Macromolecular Substances | 2 | 1991 | 122 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-jun | 2 | 2004 | 71 | 0.020 |
Why?
|
| Infant | 2 | 2013 | 2891 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 396 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2010 | 66 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2013 | 3187 | 0.020 |
Why?
|
| HIV Infections | 1 | 1998 | 791 | 0.020 |
Why?
|
| DNA | 1 | 1993 | 597 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2010 | 39 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 540 | 0.020 |
Why?
|
| Radioisotope Dilution Technique | 2 | 1987 | 14 | 0.020 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2010 | 4 | 0.020 |
Why?
|
| Receptors, Drug | 1 | 1990 | 31 | 0.020 |
Why?
|
| Manganese | 1 | 1990 | 26 | 0.020 |
Why?
|
| Terminology as Topic | 2 | 2006 | 141 | 0.020 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2009 | 13 | 0.020 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 1989 | 41 | 0.020 |
Why?
|
| Palmitic Acids | 1 | 1989 | 15 | 0.020 |
Why?
|
| Prostaglandin Endoperoxides, Synthetic | 1 | 1989 | 52 | 0.020 |
Why?
|
| Genes | 1 | 1990 | 86 | 0.020 |
Why?
|
| Factor VII | 1 | 1989 | 8 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 536 | 0.020 |
Why?
|
| Thromboplastin | 1 | 1989 | 21 | 0.020 |
Why?
|
| Nitrogen | 1 | 2009 | 57 | 0.020 |
Why?
|
| Antioxidants | 1 | 2012 | 304 | 0.020 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 1989 | 28 | 0.020 |
Why?
|
| Long-Term Potentiation | 1 | 2010 | 53 | 0.020 |
Why?
|
| Uncoupling Protein 3 | 1 | 2009 | 13 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 1993 | 371 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2009 | 12 | 0.020 |
Why?
|
| Longevity | 1 | 2010 | 60 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2009 | 12 | 0.020 |
Why?
|
| Unfolded Protein Response | 1 | 2009 | 70 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 1989 | 123 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 1085 | 0.020 |
Why?
|
| Ceruloplasmin | 1 | 2008 | 8 | 0.020 |
Why?
|
| Cholesterol | 1 | 2010 | 331 | 0.020 |
Why?
|
| Ion Channels | 1 | 2009 | 72 | 0.020 |
Why?
|
| Histone Chaperones | 1 | 2008 | 11 | 0.020 |
Why?
|
| Ethanolamines | 1 | 1989 | 33 | 0.020 |
Why?
|
| Prostate | 1 | 2009 | 116 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2009 | 71 | 0.020 |
Why?
|
| Integrin alpha6beta1 | 1 | 2008 | 4 | 0.020 |
Why?
|
| Receptors, Vitronectin | 1 | 2008 | 11 | 0.020 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2008 | 15 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 306 | 0.020 |
Why?
|
| Recurrence | 1 | 2011 | 948 | 0.020 |
Why?
|
| RNA, Plant | 1 | 2008 | 3 | 0.020 |
Why?
|
| Genes, Plant | 1 | 2008 | 15 | 0.020 |
Why?
|
| Acridine Orange | 1 | 1988 | 3 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2008 | 112 | 0.020 |
Why?
|
| Zinc Compounds | 1 | 2008 | 9 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2008 | 92 | 0.020 |
Why?
|
| Proteomics | 1 | 2010 | 246 | 0.020 |
Why?
|
| Chicken anemia virus | 1 | 2008 | 5 | 0.020 |
Why?
|
| Chlorides | 1 | 2008 | 68 | 0.020 |
Why?
|
| Genome, Plant | 1 | 2007 | 5 | 0.020 |
Why?
|
| Arabidopsis Proteins | 1 | 2007 | 13 | 0.020 |
Why?
|
| Caspase 1 | 2 | 1999 | 22 | 0.020 |
Why?
|
| Spleen | 1 | 2008 | 301 | 0.020 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2007 | 6 | 0.020 |
Why?
|
| Adenosine Diphosphate | 1 | 1987 | 66 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2008 | 208 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2007 | 99 | 0.020 |
Why?
|
| Pargyline | 1 | 2007 | 4 | 0.020 |
Why?
|
| Butylated Hydroxytoluene | 1 | 2007 | 3 | 0.020 |
Why?
|
| Tyramine | 1 | 2007 | 16 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2013 | 2358 | 0.020 |
Why?
|
| Phylogeny | 1 | 2008 | 197 | 0.020 |
Why?
|
| Receptor, ErbB-2 | 1 | 2008 | 129 | 0.020 |
Why?
|
| Monensin | 1 | 2007 | 8 | 0.020 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2007 | 30 | 0.020 |
Why?
|
| Phenylalanine | 1 | 2007 | 22 | 0.020 |
Why?
|
| 2,4-Dinitrophenol | 2 | 1997 | 6 | 0.020 |
Why?
|
| Larynx | 1 | 2007 | 49 | 0.020 |
Why?
|
| Chelating Agents | 2 | 1997 | 47 | 0.020 |
Why?
|
| Amino Acids, Basic | 1 | 2006 | 1 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2009 | 470 | 0.020 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2007 | 59 | 0.020 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 1 | 2006 | 4 | 0.020 |
Why?
|
| Histidine | 1 | 2006 | 17 | 0.020 |
Why?
|
| Sialyltransferases | 1 | 2006 | 7 | 0.020 |
Why?
|
| Thiophenes | 1 | 2007 | 76 | 0.020 |
Why?
|
| Pharynx | 1 | 2007 | 89 | 0.020 |
Why?
|
| Electric Conductivity | 2 | 1997 | 87 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2006 | 33 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2006 | 14 | 0.020 |
Why?
|